Sabra Health Care Reit, Inc. SBRA
We take great care to ensure that the data presented and summarized in this overview for Sabra Health Care REIT, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding SBRA
View all-
Vanguard Group Inc Valley Forge, PA35MShares$598 Million0.01% of portfolio
-
Black Rock Inc. New York, NY34.4MShares$588 Million0.01% of portfolio
-
Principal Financial Group Inc Des Moines, IA22.1MShares$378 Million0.22% of portfolio
-
State Street Corp Boston, MA12.2MShares$208 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY10.3MShares$176 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA6.38MShares$109 Million0.01% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA4.7MShares$80.4 Million0.02% of portfolio
-
Lsv Asset Management Chicago, IL4.28MShares$73.2 Million0.17% of portfolio
-
Northern Trust Corp Chicago, IL4.17MShares$71.3 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC4.12MShares$70.5 Million0.01% of portfolio
Latest Institutional Activity in SBRA
Top Purchases
Top Sells
About SBRA
As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (?Senior Housing - Leased?), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (?Senior Housing - Managed?), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture. As of March 31, 2022, Sabra's real estate properties held for investment included 41,445 beds/units, spread across the United States and Canada.
Insider Transactions at SBRA
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 28
2025
|
Talya Nevo Hacohen Executive VP, CIO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
4,874
+1.47%
|
-
|
Feb 28
2025
|
Jessica Flores Executive VP & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
407
+0.56%
|
-
|
Feb 28
2025
|
Craig A. Barbarosh Director |
BUY
Grant, award, or other acquisition
|
Direct |
946
+1.74%
|
-
|
Feb 28
2025
|
Catherine Cusack Director |
BUY
Grant, award, or other acquisition
|
Direct |
833
+1.34%
|
-
|
Feb 28
2025
|
Michael J Foster Director |
BUY
Grant, award, or other acquisition
|
Direct |
946
+1.23%
|
-
|
Feb 28
2025
|
Lynne S Katzmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
946
+1.42%
|
-
|
Feb 28
2025
|
Ann Kono Director |
BUY
Grant, award, or other acquisition
|
Direct |
843
+1.74%
|
-
|
Feb 28
2025
|
Jeffrey A. Malehorn Director |
BUY
Grant, award, or other acquisition
|
Direct |
946
+0.98%
|
-
|
Feb 28
2025
|
Clifton J Porter Ii Director |
BUY
Grant, award, or other acquisition
|
Direct |
855
+1.72%
|
-
|
Feb 28
2025
|
Richard K Matros Chair, CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
14,676
+1.74%
|
-
|
Feb 28
2025
|
Michael Lourenco Costa Executive VP, CFO & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
3,858
+1.11%
|
-
|
Feb 24
2025
|
Catherine Cusack Director |
BUY
Open market or private purchase
|
Direct |
1,500
+2.42%
|
$22,500
$15.92 P/Share
|
Feb 21
2025
|
Catherine Cusack Director |
BUY
Open market or private purchase
|
Direct |
1,000
+1.66%
|
$16,000
$16.43 P/Share
|
Jan 15
2025
|
Richard K Matros Chair, CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
285,144
+25.98%
|
-
|
Jan 15
2025
|
Michael Lourenco Costa Executive VP, CFO & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
63,782
+15.77%
|
-
|
Jan 15
2025
|
Talya Nevo Hacohen Executive VP, CIO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
90,044
+21.85%
|
-
|
Jan 15
2025
|
Jessica Flores Executive VP & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,085
-5.36%
|
$69,445
$17.0 P/Share
|
Jan 15
2025
|
Jessica Flores Executive VP & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
10,048
+11.65%
|
-
|
Jan 08
2025
|
Richard K Matros Chair, CEO and President |
BUY
Bona fide gift
|
Indirect |
151,909
+8.55%
|
-
|
Jan 08
2025
|
Richard K Matros Chair, CEO and President |
SELL
Bona fide gift
|
Direct |
151,909
-22.36%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 810K shares |
---|---|
Open market or private purchase | 9.5K shares |
Bona fide gift | 152K shares |
Payment of exercise price or tax liability | 202K shares |
---|---|
Bona fide gift | 153K shares |
Open market or private sale | 10K shares |